Table 4.
Toxic effects | N (%) |
PPE | 22 (17) |
Grade 1 | 11 (9) |
Grade 2 | 9 (7) |
Grade 3 | 1 (1) |
Exanthema | 18 (14) |
Mucositis | 16 (12) |
Nausea/Vomiting | 12 (9) |
Fatigue | 11 (9) |
Infectious event | 12 (9) |
Alopecia (only grade 1 and 2) | 7 (5) |
Gastrointestinal problems | 6 (5) |
Respiratory problems | 5 (4) |
Cardiac problems* | 5 (4) |
Neutropenia grade 4 | 3 (2) |
Thrombocytopenia grade 4 | 2 (2) |
Thromboembolic event | 2 (2) |
Cough | 2 (2) |
Hypersensitivity reaction | 2 (2) |
*Including 2 patients with severe congestive heart failure, one case of which was fatal. 4 patients with cardiac adverse events during PLD therapy harboured 2 cardiac risk factors, whereas the one patient with fatal exacerbation of heart failure was characterized by 5 cardiac risk factors.